Radiopharmaceutical Therapy Referral
We currently welcome therapy referrals for patients with metastatic prostate cancer and neuroendocrine tumors.
Radiopharmaceutical therapy at BAMF Health begins with a comprehensive consultation with BAMF Health Medical Director Dr. Brandon Mancini. These in-depth conversations offer patients further clarity about their disease and eligibility for radioligand treatment. Your patients remain under your care as needed, and we keep you informed throughout their time with us.
After each treatment, patients receive a SPECT/CT scan to assess treatment uptake and inform the treatment plan going forward.
Convenient Referral Options
- Refer using your own EMR and fax to us
- Refer using your own EMR and upload to MiHIN/holon (BAMF Health – Molecular Therapy Clinic)
- Use our referral form and fax to us
- Use our referral form and upload to MiHIN/holon
BAMF Health referral FAX number: 616-253-8365
Alzheimer's Evaluation and Treatment Referral
BAMF Health offers integrated Alzheimer’s care, from evaluation to FDA-approved treatment, all in one location. We begin with a cognitive and medical assessment, followed by amyloid PET imaging if indicated.
Patients with mild cognitive impairment and confirmed amyloid pathology may be eligible for infusion therapy, administered in our Molecular Therapy Clinic just above our imaging suite. This setup ensures seamless care and efficient follow-up. Our team guides you and your patient through every step, making referrals simple and coordinated.
Clinical Trial Referrals
BAMF Health is a national leader in radiopharmaceutical clinical trials, offering patients access to cutting-edge diagnostics and therapies not available elsewhere. Our dedicated and experienced team provides expert care and prioritizes close communication with referring physicians throughout the trial process.
An up-to-date list of current and upcoming clinical trials, including eligibility criteria, is available on our website.